awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42391592-B4AF8F74-3E4E-4EB7-ABC2-44A6DF3D32C3
Q42391592-B4AF8F74-3E4E-4EB7-ABC2-44A6DF3D32C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42391592-B4AF8F74-3E4E-4EB7-ABC2-44A6DF3D32C3
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis.
P2860
Q42391592-B4AF8F74-3E4E-4EB7-ABC2-44A6DF3D32C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42391592-B4AF8F74-3E4E-4EB7-ABC2-44A6DF3D32C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d7e3b6530ebb438b9bd6a5b180a4890ed2b766e
P2860
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulatin